89 related articles for article (PubMed ID: 2118569)
1. Vasodilator activity of endothelin-1 and endothelin-3: rapid development of cross-tachyphylaxis and dependence on the rate of endothelin administration.
Le Monnier de Gouville AC; Lippton H; Cohen G; Cavero I; Hyman A
J Pharmacol Exp Ther; 1990 Sep; 254(3):1024-8. PubMed ID: 2118569
[TBL] [Abstract][Full Text] [Related]
2. Hemodynamic and pharmacological evaluation of the vasodilator and vasoconstrictor effects of endothelin-1 in rats.
Le Monnier de Gouville AC; Mondot S; Lippton H; Hyman A; Cavero I
J Pharmacol Exp Ther; 1990 Jan; 252(1):300-11. PubMed ID: 2405151
[TBL] [Abstract][Full Text] [Related]
3. A comparison of the hemodynamic effects of endothelin-1 and sarafotoxin S6b in conscious rats.
Han SP; Trapani AJ; Fok KF; Westfall TC; Knuepfer MM
J Pharmacol Exp Ther; 1991 Jan; 256(1):183-8. PubMed ID: 1988658
[TBL] [Abstract][Full Text] [Related]
4. Functional evidence for different endothelin receptors in the lung.
Lippton HL; Hauth TA; Cohen GA; Hyman AL
J Appl Physiol (1985); 1993 Jul; 75(1):38-48. PubMed ID: 8376289
[TBL] [Abstract][Full Text] [Related]
5. Effects of the dual metallopeptidase inhibitor, MDL 100,240, on regional haemodynamic responses to vasoactive peptides in conscious rats.
Gardiner SM; Kemp PA; Brunner-Ferber F; Bennett T
Br J Pharmacol; 1997 Dec; 122(8):1687-93. PubMed ID: 9422815
[TBL] [Abstract][Full Text] [Related]
6. Cross tachyphylaxis to endothelin isopeptide-induced hypotension: a phenomenon not seen with proendothelin.
Le Monnier de Gouville AC; Cavero I
Br J Pharmacol; 1991 Sep; 104(1):77-84. PubMed ID: 1786522
[TBL] [Abstract][Full Text] [Related]
7. Analysis of cardiovascular and pulmonary responses to endothelin-1 and endothelin-3 in the anesthetized cat.
Minkes RK; Bellan JA; Saroyan RM; Kerstein MD; Coy DH; Murphy WA; Nossaman BD; McNamara DB; Kadowitz PJ
J Pharmacol Exp Ther; 1990 Jun; 253(3):1118-25. PubMed ID: 1972748
[TBL] [Abstract][Full Text] [Related]
8. Use of an indwelling catheter for examining cardiovascular responses to pericardial administration of bradykinin in rat.
McDermott DA; Meller ST; Gebhart GF; Gutterman DD
Cardiovasc Res; 1995 Jul; 30(1):39-46. PubMed ID: 7553722
[TBL] [Abstract][Full Text] [Related]
9. Safety and pharmacologic activity of a new nitrate ester, ITF 296, after intravenous administration in healthy volunteers.
Sardina M; Love R; Mizrahi J; Monzani V; Bianchini C
J Cardiovasc Pharmacol; 1995; 26 Suppl 4():S72-9. PubMed ID: 8839230
[TBL] [Abstract][Full Text] [Related]
10. Differential pharmacological profile of endothelin-1 and its precursor, big endothelin.
Le Monnier de Gouville AC; Cavero I
J Cardiovasc Pharmacol; 1991; 17 Suppl 7():S362-5. PubMed ID: 1725381
[TBL] [Abstract][Full Text] [Related]
11. Effects of big endothelin-1 in comparison with endothelin-1 on the microvascular blood flow velocity and diameter of rat mesentery in vivo.
Abdelhalim MA
Microvasc Res; 2006 Nov; 72(3):108-12. PubMed ID: 17028040
[TBL] [Abstract][Full Text] [Related]
12. Circulatory responses to endothelin-1 and nitric oxide with special reference to endotoxin shock and nitric oxide inhalation.
Weitzberg E
Acta Physiol Scand Suppl; 1993; 611():1-72. PubMed ID: 8379340
[TBL] [Abstract][Full Text] [Related]
13. Systemic, pulmonary and coronary haemodynamic actions of the novel dopamine receptor agonist in awake pigs at rest and during treadmill exercise Z1046.
Duncker DJ; Haitsma DB; van der Geest IE; Stubenitsky R; van Meegen JR; Man in't Veld AJ; Verdouw PD
Br J Pharmacol; 1997 Mar; 120(6):1101-13. PubMed ID: 9134223
[TBL] [Abstract][Full Text] [Related]
14. Endothelin produces pulmonary vasoconstriction and systemic vasodilation.
Lippton HL; Hauth TA; Summer WR; Hyman AL
J Appl Physiol (1985); 1989 Feb; 66(2):1008-12. PubMed ID: 2565328
[TBL] [Abstract][Full Text] [Related]
15. Effects of salt intake and angiotensin II on vascular reactivity to endothelin-1.
Ballew JR; Watts SW; Fink GD
J Pharmacol Exp Ther; 2001 Feb; 296(2):345-50. PubMed ID: 11160616
[TBL] [Abstract][Full Text] [Related]
16. Why big endothelin-1 lacks a vasodilator response.
Haleen SJ; Davis LS; LaDouceur DM; Keiser JA
J Cardiovasc Pharmacol; 1993; 22 Suppl 8():S271-3. PubMed ID: 7509963
[TBL] [Abstract][Full Text] [Related]
17. Analysis of responses to endothelins in the rabbit pulmonary and systemic vascular beds.
Lippton HL; Ohlstein EH; Summer WR; Hyman AL
J Appl Physiol (1985); 1991 Jan; 70(1):331-41. PubMed ID: 2010389
[TBL] [Abstract][Full Text] [Related]
18. Hemodynamic effects of endothelin after systemic and central nervous system administration in the conscious rat.
Sirén AL; Feuerstein G
Neuropeptides; 1989; 14(4):231-6. PubMed ID: 2695855
[TBL] [Abstract][Full Text] [Related]
19. Evidence for distinct endothelin receptors in the pulmonary vascular bed in vivo.
Lippton HL; Cohen GA; Knight M; McMurtry IF; Gillot D; Arena F; Summer W; Hyman AL
J Cardiovasc Pharmacol; 1991; 17 Suppl 7():S370-3. PubMed ID: 1725383
[TBL] [Abstract][Full Text] [Related]
20. Dilatation of the mesenteric vascular bed of the dog produced by a peptide, urotensin I.
MacCannell K; Lederis K
J Pharmacol Exp Ther; 1977 Oct; 203(1):38-46. PubMed ID: 909056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
